Infectious Disease Diagnostics Market is segmented by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) and Geography.

The Infectious Disease Diagnostics Market is anticipated to grow at a CAGR of 6.9% during the forecast period reaching a market size value of USD 42.95 billion by 2028.

Infectious Disease Diagnostics is a process where infectious diseases are characterized and often identified by its causative agent. It involves molecular methods, biochemical screening, microscopy, culturing of infectious agents, as well as conducting diagnostics tests and efficient clinical presentations. Some known infectious diseases like, severe acute respiratory syndrome, Middle East respiratory syndrome, swine flu, chikungunya, Ebola, Zika and avian flu are also have been easily diagnosed and prevented at an early stag.

COVID-19 Analysis

An apparent restraint is the negative impact brought upon by the pandemic because of the lock downs and implemented protocols which may have disrupted the supply chain, distribution and manufacturing in facilities of prominent companies. This can be considered a big set back in the growth of the diagnostic devices market because if manufacturing and distribution of products are affected, production and sales will also be negatively affected making it for challenging for these companies to meet demands of end users. Another growth hindrance for the infection disease diagnostics market is the inadequate reimbursement and unfavorable response to the market.

However, there are also positive growth outcome in the market because of the pandemic. The COVID-19 has caused a high demand for POC diagnostics kits which are used to diagnose early signs and symptoms of the infectious disease as well as give additional information on how to control corona virus’ spread. The respond to COVID-19 outbreak is to immediately understand the virus, thus, manufacturers grabbed this opportunity to develop easy-to-use testing kits that can be done outside the metes of laboratories.

The market’s growth is mainly attributed to factors such as the increasing awareness for diagnostic tests and its benefits of early detection, growing support in funding for research on infectious diseases diagnostics, and concentration on decentralized point-of-care testing services instead of just focusing on centralized laboratories.

Key Findings in the Global Infectious Disease Diagnostics Market

In terms of technology, the immunodiagnostics segment is anticipated to have the overall largest share in the market in 2020. the growth of this segments is mainly attributed to the high demand of using immunoassays with respect to infectious disease testing, innovations in novel testing, trend in automation, growing awareness on proper health, and the complications are reduced in the instruments utilized.

In terms of products and services, the consumable segment is projected to have the fastest CAGR growth in 2021-2028. This rapid growth is caused by growing emergence of infectious diseases, a growing demand from the populace to immediately identify the diseases, prevalence of using kits and reagents aiding the identification of the various causing diseases. With the looming threats of corona virus, this market segment is anticipated to grow further because governments are demanding medical research institutions and manufacturers to develop on-the-go testing kits and assays that can help in detecting the virus at an early phase.

In terms of disease type, the hepatitis segment is projected to have the overall largest share in the market in 2020. this id due to the growing number of blood transfusions as well as donations, increasing number of Hepatitis B and C cases, lastly, point of care instruments and kits providing better benefits.

Regional Market Analysis

In terms of region, North America dominates the market in 2020. on the other hand, Asia Pacific Region is projected to grow at the most rapid CAGR in 2021-2028. the factors for such growth are, urbanization, countless investments made to improve medical infrastructure, the concerning issue of containing infectious diseases, and government initiatives to deliver an easy access to diagnostic services which may help in the prevention and early detection of the infectious diseases.

Share and Competition among Key Players

The globally established key players in this market are as follows, Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.).

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2021 – 2028)
• Data breakdown for every market segment (2021 – 2028)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown

Product & Solution Analysis (Revenue, USD Million, 2021 - 2028)

• Consumables
• Instruments
• Software & Services

Technology Analysis (Revenue, USD Million, 2021 - 2028)

• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing and Next-Generation Sequencing (NGS)
• DNA Microarray Technology
• Other technologies
(Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification)

Disease Type Analysis (Revenue, USD Million, 2021 - 2028)

• Hepatitis
• Human Immunodeficiency Virus (HIV)
• Hospital-Acquired Infections (HAIS)
• Human Papilloma virus (HPV)
• Tuberculosis (TB)
• Influenza
• Other Diseases
(Other diseases comprise of measles, smallpox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, corona virus disease, and whooping cough)

End User Analysis (Revenue, USD Million, 2021 - 2028)

• Hospital/Clinical Laboratories
• Reference Laboratories
• Academics/Research Institutes
• Other End Users
(Other end-users comprise of physician offices, nursing facilities, and home healthcare agencies)

Region Analysis (Revenue, USD Million, 2020 – 2028)

• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• UAE
• Qatar
• Saudi Arabia
• Japan
• Africa
• Rest of World
Available Versions:
• United States Infectious Disease Diagnostics Industry Research Report
• Europe Infectious Disease Diagnostics Industry Research Report
• Asia Pacific Infectious Disease Diagnostics Industry Research Report

Need report on this market for specific region or Country? Or need a customized report as per your need? Want to know discounts as available?

Email US

David Correa

david@marketdecipher.com

Or Fill the form below "Sample Request Form" with your queries in message box.